Benitec Biopharma Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q3 2019 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Benitec Biopharma Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q3 2019 to Q3 2024.
- Benitec Biopharma Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending September 30, 2024 was $21.7M, a 22.4% decline year-over-year.
- Benitec Biopharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $68M, a 325% increase from 2023.
- Benitec Biopharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $16M.
- Benitec Biopharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $22.5M, a 1172% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)